换一批Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study.
第一作者：
Lieske H,Schrijver
第一单位：
Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
作者：
Lieske H,Schrijver [1]
;
Håkan,Olsson [2]
;
Kelly-Anne,Phillips [3]
;
Mary Beth,Terry [4]
;
David E,Goldgar [5]
;
Karin,Kast [6]
;
Christoph,Engel [7]
;
Thea M,Mooij [1]
;
Julian,Adlard [8]
;
Daniel,Barrowdale [9]
;
Rosemarie,Davidson [10]
;
Ros,Eeles [11]
;
Steve,Ellis [9]
;
D Gareth,Evans [12]
;
Debra,Frost [9]
;
Louise,Izatt [13]
;
Mary E,Porteous [14]
;
Lucy E,Side [15]
;
Lisa,Walker [16]
;
Pascaline,Berthet [17]
;
Valérie,Bonadona [18]
;
Dominique,Leroux [19]
;
Emmanuelle,Mouret-Fourme [20]
;
Laurence,Venat-Bouvet [21]
;
Saundra S,Buys [22]
;
Melissa C,Southey [23]
;
Esther M,John [24]
;
Wendy K,Chung [25]
;
Mary B,Daly [26]
;
Anita,Bane [27]
;
Christi J,van Asperen [28]
;
Encarna B,Gómez Garcia [29]
;
Marian J E,Mourits [30]
;
Theo A M,van Os [31]
;
Marie-José,Roos-Blom [1]
;
Michael L,Friedlander [32]
;
Sue-Anne,McLachlan [33]
;
Christian F,Singer [34]
;
Yen Y,Tan [34]
;
Lenka,Foretova [35]
;
Marie,Navratilova [36]
;
Anne-Marie,Gerdes [37]
;
Trinidad,Caldes [38]
;
Jacques,Simard [39]
;
Edith,Olah [40]
;
Anna,Jakubowska [41]
;
Brita,Arver [42]
;
Ana,Osorio [43]
;
Catherine,Noguès [44]
;
Nadine,Andrieu [45]
;
Douglas F,Easton [9]
;
Flora E,van Leeuwen [1]
;
John L,Hopper [46]
;
Roger L,Milne [47]
;
Antonis C,Antoniou [9]
;
Matti A,Rookus [1]
;
EMBRACE, GENEPSO, BCFR, HEBON, kConFab, and IBCCS
作者单位：
Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
[1]
Department of Oncology, Lund University Hospital.
[2]
Lund University, Lund, Sweden; Sir Peter MacCallum Department of Oncology.;Division of Cancer Medicine.;Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
[3]
Department of Epidemiology.
[4]
Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT.
[5]
Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
[6]
Oncology and Pathology, Department of Clinical Sciences Lund.;Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany.
[7]
Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK.
[8]
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK.
[9]
Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK.
[10]
Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK.
[11]
Genomic Medicine, Manchester Academic Health Sciences Centre, Institute of Human Development, Manchester University, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
[12]
Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
[13]
South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, UK.
[14]
North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, UK.
[15]
Oxford Regional Genetics Service, Churchill Hospital, Oxford, UK.
[16]
Centre François Baclesse, Caen, France.
[17]
Université Claude Bernard Lyon 1, Villeurbanne, France.
[18]
CHU de Grenoble, Hôpital Couple-Enfant, Département de Génétique, Grenoble, France.
[19]
Service de Génétique Oncologique, Hôpital René Huguenin/Institut Curie, Saint-Cloud, France.
[20]
Hôpital Universitaire Dupuytren, Service d'Oncologie Médicale, Limoges, France.
[21]
Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT.
[22]
Genetic Epidemiology Laboratory, Department of Pathology.;Precision Medicine, School of Clinical Science at Monash Health, Monash University, Victoria, Australia.
[23]
Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA.;Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.
[24]
Department of Pediatrics and Medicine, Columbia University, New York, NY.
[25]
Division of Population Science, Fox Chase Cancer Center, Philadelphia, PA.
[26]
Department of Pathology and Molecular Medicine, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, Ontario, Canada.;Department of Oncology-Pathology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
[27]
Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
[28]
Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.
[29]
Department of Gynaecologic Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
[30]
Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands.
[31]
Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.;Department of Medical Oncology, Prince of Wales Hospital, Randwick, Australia.
[32]
Department of Medicine, St. Vincent's Hospital, University of Melbourne, Parkville, Victoria, Australia.;Division of Cancer Medicine.;Department of Medical Oncology, St Vincent's Hospital, Fitzroy, Australia.
[33]
Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
[34]
Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic, Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology.
[35]
Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic, Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology.;Medical Faculty, University of Cologne and University Hospital Cologne, Germany.
[36]
Department of Clincial Genetics, Rigshospitalet, København, Denmark.
[37]
Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, CIBERONC, Martin Lagos s/n, Madrid, Spain.
[38]
Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada.
[39]
Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
[40]
Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
[41]
Department of Oncology-Pathology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
[42]
Human Genetics Group, Spanish National Cancer Centre, Madrid, Spain.
[43]
Oncogénétique Clinique, Institut Paoli-Calmettes and Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France.
[44]
INSERM U900, Paris, France.;Institut Curie, Paris, France.;Ecole des Mines de Paris, ParisTech, Fontainebleau, France.
[45]
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
[46]
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.;Cancer Epidemiology Centre, Cancer Council Victoria, Victoria, Australia.
[47]
DOI
10.1093/jncics/pky023
PMID
31360853
发布时间
2025-05-30
- 浏览0
JNCI cancer spectrum
JNCI cancer spectrum
2018年2卷2期
pky023页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
